Oncology Pipeline Analytics


biological autoimmune therapeutics          Published December 2018 •  Catalog no. JPA492K  •  Price US $2,850



The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. Their approaches have attracted a growing number of drug developers anxious to profit from therapies that can ease the physical, psychological and emotional burden of cancer. Our analytics analysis of current active oncology trial data reveals these factors and how they are affecting the oncology drug development landscape. By combining data on the oncology drug delivery landscape with the relational power of analytics we’ve created a unique information resource that provides insight and clarity to market sector activity and competitive positioning within the oncology therapeutics space. By grouping and formatting information into visualizations that are easy to digest, readers gain a new and revealing perspective on the oncology drug development market.

Bar_Graph Oncology Pipeline Analytics Report Brochure (Download PDF)

Blue document  Oncology Pipeline Analytics Report Order Form (Download PDF)

 

  Order Online

 

Oncology Pipeline Analytics – What You Will Learn

•  Who are the leading developers in the current crop of oncology drugs in development? What are their activities and what is their position in therapeutic oncology markets?
•  What are the most frequently trailed therapeutic oncology drugs? What is the clinical strategy? How many trials are under way?
•  What are the major factors driving the oncology pipeline development market landscape?
•  What is the size of the oncology clinical trial market today, who are the market share leaders, and what will the market share look like in 2024?
•  How important are drug partnership relationships in the oncology drug development space?
•  Which indications are the focus of the highest level of clinical trial activity? How well-positioned are the leading oncology drug suppliers as the pace of oncology product introductions accelerates?
•  What are the significant economic, technology, and regulatory factors affecting the market?


Oncology Pipeline Analytics – Summary of Contents

 

Executive Summary

Drug Development Challenges in Oncology Therapeutics

Biological Drugs

Biosimilars

Small Molecule Drugs 

Leading Development-stage Oncology Therapeutics

atezolizumab

PD-1 & PD-L1

durvalumab

HDAC Inhibitors

nivolumab

BET Inhibitors

CAR-T cell therapy

Oncolytic Viruses

STAT3 Inhibitors

carbozantinib

Anti-LAG3 mAb

BTK Inhibitor

PARP Inhibitors

 

Oncology Clinical Trial Activity by Sponsor & Disease Segment

Bladder Cancer

Brain Cancer

Breast Cancer

Colorectal Cancer

Gastric Cancer

Head and Neck Cancer

Hematological Malignancies

Hepatic Cancer

Kidney Cancer

Leukemia

Lung Cancer

Lymphoma

Multiple Myeloma

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer

Sarcomas

Skin Cancer

Solid Tumors

Other Cancers

Company Profiles


Tables, Charts and Visualizations

1. Pipeline Activity by Cancer Segment (Bubble Chart)
2. Sponsors of Active Oncology Trials (Heat Map)
3. New BLAs by Application 2005-2017 (Dot Matric)
4. Biological Drug Ecosystem (Global Map)
5. atezolizumab – Trials by Disease Segment (Circle Grid)
6. PD-1 / PD-L1 Inhibitors – Trials by Disease Segment (Circle Grid)
7. PD-1 / PD-L1 Inhibitors – Active Trials by Sponsor (Pie Chart)
8. PD-1 / PD-L1 Inhibitors – Active Trials by Disease Segment (Pie Chart)
9. durvalumab – Trials by Disease Segment (Circle Grid)
10. durvalumab – Active Trials by Sponsor (Pie Chart)
11. durvalumab – Active Trials by Disease Segment (Pie Chart)
12. HDAC Inhibitors – Active Trials by Disease Segment (Circle Grid)
13. HDAC Inhibitors – Active Trials by Sponsor (Pie Chart)
14. HDAC inhibitors – Active Trials by Disease Segment (Pie Chart)
15. nivolumab – Active Trials by Disease Segment (Circle Grid)
16. nivolumab – Active Trials by Disease Segment (Pie Chart)
17. BET Inhibitors – – Active Trials by Disease Segment (Circle Grid)
18. BET Inhibitors – Active Trials by Sponsor (Pie Chart)
19. CAR-T cell therapy – Active Trials by Sponsor (Pie Chart)
20. CAR-T cell therapy – Active Trials by Disease Segment (Pie Chart)
21. Oncolytic Viruses – Active Trials by Disease Segment (Circle Grid)
22. Oncolytic Viruses – Active Trials by Sponsor (Pie Chart)
23. Oncolytic Viruses – Active Trials by Disease Segment (Circle Grid)
24. STAT3 Inhibitors – Active Trials by Sponsor (Pie Chart)
25. STAT3 Inhibitors – Active Trials by Disease Segment (Pie Chart)
26. carbozantinib – Active Trials by Disease Segment (Pie Chart)
27. Anti-LAG3 mAb – Active Trials by Sponsor (Pie Chart)
28. Anti-LAG3 mAb – Active Trials by Disease Segment (Pie Chart)
29. BTK Inhibitor – Active Trials by Sponsor (Pie Chart)
30. BTK Inhibitor – Active Trials by Disease Segment (Pie Chart)
31. PARP Inhibitors – Active Trials by Sponsor (Pie Chart)
32. PARP Inhibitors – Active Trials by Disease Segment (Pie Chart)
33. Bladder Cancer – Active Oncology Trials by Phase (Bar Graph)
34. Brain Cancer – Active Trials by Disease Segment (Bar Graph)
35. Breast Cancer – Active Trials by Disease Segment (Bar Graph)
36. Colorectal Cancer – Active Trials by Disease Segment (Bar Graph)
37. Gastric Cancer – Active Trials by Disease Segment (Bar Graph)
38. Head and Neck Cancer – Active Trials by Disease Segment (Bar Graph)
39. Hematological Malignancies – Active Trials by Disease Segment (Bar Graph)
40. Hepatic Cancer – Active Trials by Disease Segment (Bar Graph)
41. Kidney Cancer – Active Trials by Disease Segment (Bar Graph)
42. Leukemia – Active Trials by Disease Segment (Bar Graph)
43. Lung Cancer – Active Trials by Disease Segment (Bar Graph)
44. Lymphoma – Active Trials by Disease Segment (Bar Graph)
45. Multiple Myeloma – Active Trials by Disease Segment (Bar Graph)
46. Ovarian Cancer – Active Trials by Disease Segment (Bar Graph)
47. Pancreatic Cancer – Active Trials by Disease Segment (Bar Graph)
48. Prostate Cancer – Active Trials by Disease Segment (Bar Graph)
49. Sarcomas – Active Trials by Disease Segment (Bar Graph)
50. Skin Cancer – Active Trials by Disease Segment (Bar Graph)
51. Solid Tumors – Active Trials by Disease Segment (Bar Graph)
52. Other Cancers – Active Trials by Disease Segment (Bar Graph)
53. AbbVie – Clinical Trial Activity by Disease Segment (Bubble Chart)
54. AbbVie – Active Oncology Trial Details (Table)
55. AbbVie – Number of Active Oncology Trials by Drug Class (Heat Map)
56. Amgen – Clinical Trial Activity by Disease Segment (Bubble Chart)
57. Amgen – Active Oncology Trial Details (Table)
58. Amgen – Number of Active Oncology Trials by Drug Class (Heat Map)
59. AstraZeneca – Clinical Trial Activity by Disease Segment (Bubble Chart)
60. AstraZeneca – Active Oncology Trial Details (Table)
61. AsetraZeneca – Number of Active Oncology Trials by Drug Class (Heat Map)
62. Bayer Pharmaceuticals – Clinical Trial Activity by Disease Segment (Bubble Chart)
63. Bayer Pharmaceuticals – Active Oncology Trial Details (Table)
64. Bayer Pharmaceuticals – Number of Active Oncology Trials by Drug Class (Heat Map)
65. Boehringer Ingelheim – Clinical Trial Activity by Disease Segment (Bubble Chart)
66. Boehringer Ingelheim – Active Oncology Trial Details (Table)
67. Boston Biomedical – Clinical Trial Activity by Disease Segment (Bubble Chart)
68. Boston Biomedical – Active Oncology Trial Details (Table)
69. Bristol-Myers Squibb – Clinical Trial Activity by Disease Segment (Bubble Chart)
70. Bristol-Myers Squibb – Active Oncology Trial Details (Table)
71. Bristol-Myers Squibb – Active Oncology Trial Details (Table)
72. Bristol Myers Squibb – Number of Active Oncology Trials by Drug Class (Heat Map)
73. Celgene – Clinical Trial Activity by Disease Segment (Bubble Chart)
74. Celgene – Active Oncology Trial Details (Table)
75. Celgene – Number of Active Oncology Trials by Drug Class (Heat Map)
76. Celldex Therapeutics – Clinical Trial Activity by Disease Segment (Bubble Chart)
77. Celldex Therapeutics – Active Oncology Trial Details (Table)
78. Eisai – Clinical Trial Activity by Disease Segment (Bubble Chart)
79. Eisai – Active Oncology Trial Details (Table)
80. Eli Lilly – Clinical Trial Activity by Disease Segment (Bubble Chart)
81. Eli Lily – Active Oncology Trial Details (Table)
82. Eli Lilly – Number of Active Oncology Trials by Drug Class (Heat Map)
83. EMD Serono- Clinical Trial Activity by Disease Segment (Bubble Chart)
84. EMD Serono – Active Oncology Trial Details (Table)
85. EMD Serono – Number of Active Oncology Trials by Drug Class (Heat Map)
86. Exelxis – Clinical Trial Activity by Disease Segment (Bubble Chart)
87. Exelixis – Active Oncology Trial Details (Table)
88. Genentech – Clinical Trial Activity by Disease Segment (Bubble Chart)
89. Genentech – Active Oncology Trial Details (Table)
90. Genentech – Active Oncology Trial Details (Table)
91. Genentech – Number of Active Oncology Trials by Drug Class (Heat Map)
92. Gilead Sciences – Clinical Trial Activity by Disease Segment (Bubble Chart)
93. Gilead Sciences – Active Oncology Trial Details (Table)
94. GlaxoSmithKline – Clinical Trial Activity by Disease Segment (Bubble Chart)
95. GlaxoSmithKline – Active Oncology Trial Details (Table)
96. Incyte – Clinical Trial Activity by Disease Segment (Bubble Chart)
97. Incyte – Active Oncology Trial Details (Table)
98. Janssen Research & Development – Clinical Trial Activity by Disease Segment (Bubble Chart)
99. Janssen Research & Development – Active Oncology Trial Details (Table)
100. Janssen Research & Development – Number of Active Oncology Trials by Drug Class (Heat Map)
101. Karyopharm Therapeutics – Clinical Trial Activity by Disease Segment (Bubble Chart)
102. Karyopharm Therapeutics – Active Oncology Trial Details (Table)
103. Leap Therapeutics – Clinical Trial Activity by Disease Segment (Bubble Chart)
104. Leap Therapeutics – Active Oncology Trial Details (Table)
105. MacroGenics – Clinical Trial Activity by Disease Segment (Bubble Chart)
106. MacroGenics – Active Oncology Trial Details (Table)
107. MedImmune – Clinical Trial Activity by Disease Segment (Bubble Chart)
108. MedImmune – Active Oncology Trial Details (Table)
109. MedImmune – Number of Active Oncology Trials by Drug Class (Heat Map)
110. Merck – Clinical Trial Activity by Disease Segment (Bubble Chart)
111. Merck – Active Oncology Trial Details (Table)
112. Merck – Number of Active Oncology Trials by Drug Class (Heat Map)
113. Novartis Oncology – Clinical Trial Activity by Disease Segment (Bubble Chart)
114. Novartis Oncology – Active Oncology Trial Details (Table)
115. Novartis Oncology – Active Oncology Trial Details (Table)
116. Novartis Oncology – Active Oncology Trial Details (Table)
117. Novartis Oncology – Number of Active Oncology Trials by Drug Class (Heat Map)
118. Pfizer – Clinical Trial Activity by Disease Segment (Bubble Chart)
119. Pfizer – Active Oncology Trial Details (Table)
120. Pfizer – Number of Active Oncology Trials by Drug Class (Heat Map)
121. Roche – Clinical Trial Activity by Disease Segment (Bubble Chart)
122. Roche – Active Oncology Trial Details (Table)
123. Seattle Genetics – Clinical Trial Activity by Disease Segment (Bubble Chart)
125. Seattle Genetics – Active Oncology Trial Details (Table)
126. Takeda Technology – Clinical Trial Activity by Disease Segment (Bubble Chart)
127. Takeda Technology – Active Oncology Trial Details (Table)
128. Tesaro – Clinical Trial Activity by Disease Segment (Bubble Chart)
129. Tesaro – Active Oncology Trial Details (Table)